Karamese Murat, Aydogdu Sabiha, Karamese Selina Aksak, Altoparlak Ulku, Gundogdu Cemal
Department of Microbiology, Medical Faculty, Kafkas University, Kars, Turkey E-mail :
Asian Pac J Cancer Prev. 2015;16(10):4199-202. doi: 10.7314/apjcp.2015.16.10.4199.
Hepatitis B virus infection is one of the major world health problems. Epigallocatechin-3 gallate is the major component of the polyphenolic fraction of green tea and it has an anti-viral, anti-mutagenic, anti- tumorigenic, anti-angiogenic, anti-proliferative, and/or pro-apoptotic effects on mammalian cells. In this study, our aim was to investigate the inhibition of HBV replication by epigallocatechin-3 gallate in the Hep3B2.1-7 hepatocellular carcinoma cell line.
HBV-replicating Hep3B2.1-7 cells were used to investigate the preventive effects of epigallocatechin-3 gallate on HBV DNA replication. The expression levels of HBsAg and HBeAg were determined using ELISA. Quantitative real-time-PCR was applied for the determination of the expression level of HBV DNA.
Cytotoxicity of epigallocathechin-3-gallate was not observed in the hepatic carcinoma cell line when the dose was lower than 100 μM. The ELISA method demonstrated that epigallocatechin-3 gallate have strong effects on HBsAg and HBeAg levels. Also it was detected by real-time PCR that epigallocatechin-3 gallate could prevent HBV DNA replication.
The obtained data pointed out that although the exact mechanism of HBV DNA replication and related diseases remains unclear, epigallocatechin-3 gallate has a potential as an effective anti-HBV agent with low toxicity.
乙型肝炎病毒感染是世界主要的健康问题之一。表没食子儿茶素没食子酸酯是绿茶多酚成分的主要组成部分,对哺乳动物细胞具有抗病毒、抗诱变、抗肿瘤、抗血管生成、抗增殖和/或促凋亡作用。在本研究中,我们的目的是研究表没食子儿茶素没食子酸酯对Hep3B2.1-7肝癌细胞系中乙肝病毒复制的抑制作用。
使用乙肝病毒复制的Hep3B2.1-7细胞来研究表没食子儿茶素没食子酸酯对乙肝病毒DNA复制的预防作用。采用酶联免疫吸附测定法(ELISA)测定乙肝表面抗原(HBsAg)和乙肝e抗原(HBeAg)的表达水平。应用定量实时聚合酶链反应(qRT-PCR)测定乙肝病毒DNA的表达水平。
当表没食子儿茶素没食子酸酯剂量低于100μM时,未在肝癌细胞系中观察到细胞毒性。ELISA法表明表没食子儿茶素没食子酸酯对HBsAg和HBeAg水平有显著影响。实时PCR检测还发现表没食子儿茶素没食子酸酯可以抑制乙肝病毒DNA复制。
获得的数据指出,虽然乙肝病毒DNA复制的确切机制及相关疾病仍不清楚,但表没食子儿茶素没食子酸酯具有作为低毒性有效抗乙肝病毒药物的潜力。